TickerFactsScreenerDevelopers

Esperion Therapeutics, Inc. (ESPR) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$38.16M2016: -$47.73M2017: -$131.30M2018: -$148.64M2019: -$70.34M2020: -$85.18M2021: -$263.81M2022: -$174.83M2023: -$135.49M2024: -$23.65M2025: -$13.09M-$13.09M
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$13.09M+44.6%
2024-$23.65M+82.5%
2023-$135.49M+22.5%
2022-$174.83M+33.7%
2021-$263.81M-209.7%
2020-$85.18M-21.1%
2019-$70.34M+52.7%
2018-$148.64M-13.2%
2017-$131.30M-175.1%
2016-$47.73M-25.1%
2015-$38.16M—